Technology | Cardiovascular Ultrasound | July 02, 2019

Philips Extends Advanced Automation on Epiq CVx Cardiovascular Ultrasound Platform

Platform provides advanced automation for right ventricle volumes and ejection fraction measurements in as little as 15 seconds, speeding exam times

3D Auto RV application image courtesy of Philips Healthcare

3D Auto RV application image courtesy of Philips Healthcare

AutoStrain LV application image courtesy of Philips Healthcare

AutoStrain LV application image courtesy of Philips Healthcare

July 2, 2019 — Philips recently announced new advanced automation capabilities on its Epiq CVx and Epiq CVxi cardiac ultrasound systems. With Release 5.0, both systems now include automated applications for 2-D assessment of the heart, as well as robust 3-D right ventricle volume and ejection fraction measurements, making accurate exams faster and easier to conduct.1 Together, the new applications provide clinicians with the means to confidently evaluate the heart’s function, increasing diagnostic confidence for patients with pulmonary hypertension, congenital heart disease, coronary disease and heart failure.

According to Philips, the company is leveraging artificial intelligence (AI) to make echo exams easier, faster and more reproducible, eliminating barriers to accessing high-quality care. The company said the new release of Epiq CVx reduces the number of touches of the system by 21 percent in each exam, which is equivalent to more than 400 exams each year.2

The AutoStrain LV application uses advanced Automatic View Recognition technology to identify the different views of the heart, providing high-quality visualization and analysis of left ventricular function – extremely important diagnostic information for patients at risk of developing cardiovascular disease. Also available are AutoStrain LA and AutoStrain RV, applications which automate the measurement of left atrial and right ventricular longitudinal strain, respectively. By creating reliable and reproducible strain measurements for the left ventricle, left atrium and right ventricle, the AutoStrain LV, LA and RV applications support clinicians treating patients with atrial fibrillation, arrhythmia and other complex heart conditions.

The 3D Auto RV application segments, identifies the borders of and aligns the views of the right ventricle, enabling clinicians to carry out the quantification and check the measurements in as little as 15 seconds.3 

These new applications expand on the advanced automation applications already available on the Epiq CVx platform, including Dynamic HeartModel, which provides a clear vision of the heart’s chambers and how well they are pumping blood – specifically on the left side, where heart failure often begins. A recent study of Dynamic HeartModel published in the European Heart Journal – Cardiovascular Imaging concluded that ‘the automated algorithm can quickly measure dynamic left ventricle and left atrial volumes and accurately analyze ejection/filling parameters’.4

The new release also adds diagnostic capabilities to the Epiq CVxi. Tailored for use in the interventional lab, the system can now also be used in the echo lab.

Beyond monitoring overall heart function, new medical fields such as cardio-oncology are using echocardiography to better assess heart health during chemotherapy, which can damage the heart if the dosage is not closely monitored. Cardio-oncology has increased the global demand for echocardiography as clinicians need to perform a deep analysis on cardiac images throughout the patient’s treatment, ensuring measurements are consistent from one exam to the next so that the results can be reliably compared.

Philips unveiled Epiq CVx Release 5.0 alongside its full suite of solutions for diagnosis and interventional guidance during the annual meeting of the American Society of Echo (ASE), June 21-25 in Portland, Ore. 

For more information: www.usa.philips.com/healthcare

 

References

1. The Philips CVx and CVxi 5.0 Diagnostic ultrasound systems are available for sale globally. The AutoStrain LV, LA, RV applications and the Dynamic Heart Model application are CE marked and U.S. Food and Drug Administration (FDA)-cleared and available for sale in Europe and in the U.S. The AI-enabled 3D AutoRV application, designed using a machine learning-based algorithm, is CE marked and FDA 510(k) pending, and is therefore available for sale in Europe but is not available for sale in the U.S.

2. Based on eight scans per day over 48 weeks.

3. Based on internal test results.

4. European Heart Journal – Cardiovascular Imaging, “Machine learning based automated dynamic quantification of left heart chambers volumes,” October 9, 2018.

Related Content

Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
Fluke Biomedical Introduces RaySafe 452 Survey Meter
Technology | Radiation Dose Management | July 11, 2019
Radiation measurement often requires different devices for varying applications, adding to the cost and complexity of...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Mednax National Cardiac Centers of Excellence Program Highlighted at SCCT 2019
News | CT Angiography (CTA) | July 11, 2019
Mednax Inc. and Mednax Radiology Solutions announced that Chief Medical Officer Ricardo C. Cury, M.D., FSCCT, will...
360 Photos | Ultrasound Imaging | July 11, 2019
This 360 degree photo shows a basic, point-of-care cardiac echocardiogram being performed using a smartphone turned i